Caseware UK (AP4) 2022.0.179 2022.0.179 2022-12-312022-12-31false2022-01-01No description of principal activity21trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 12374929 2022-01-01 2022-12-31 12374929 2021-01-01 2021-12-31 12374929 2022-12-31 12374929 2021-12-31 12374929 c:Director1 2022-01-01 2022-12-31 12374929 d:CurrentFinancialInstruments 2022-12-31 12374929 d:CurrentFinancialInstruments 2021-12-31 12374929 c:Micro-entities 2022-01-01 2022-12-31 12374929 c:AuditExempt-NoAccountantsReport 2022-01-01 2022-12-31 12374929 c:FullAccounts 2022-01-01 2022-12-31 12374929 c:PrivateLimitedCompanyLtd 2022-01-01 2022-12-31 iso4217:GBP xbrli:pure


















NEUROMODULATION SPECIALISTS LIMITED























UNAUDITED

FINANCIAL STATEMENTS



FOR THE YEAR ENDED 31 DECEMBER 2022



Registered number: 12374929

 
NEUROMODULATION SPECIALISTS LIMITED - REGISTERED NUMBER: 12374929

STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2022

2022
2022
2021
2021
Note
£
£
£
£

  

Current assets
  
34,997
-

Creditors: amounts falling due within one year
  
(176,637)
(51,510)

Net current liabilities
  
 
 
(141,640)
 
 
(51,510)

Total assets less current liabilities
  
(141,640)
(51,510)

  

Net liabilities
  
(141,640)
(51,510)


  

Capital and reserves
  
(141,640)
(51,510)


Notes


General information

The company is registered in England and Wales and its registered number is 12374929. The company is a private
company limited by shares. Its registered office is C/O Buzzacott LLP, 130 Wood Street, London, EC2V 6DL.


Average number of employees

The average monthly number of employees, including directors, during the year was 2 (2021 -1).


Directors' confirmations

The directors consider that the company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
 
Page 1

 
NEUROMODULATION SPECIALISTS LIMITED - REGISTERED NUMBER: 12374929
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 DECEMBER 2022


These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




Dr T L Yearwood
Director

Date: 6 July 2023

The notes on page 2 form part of these financial statements.

Page 2